Arcturus Therapeutics Holdings Inc. · NASDAQ:ARCT
The Vanguard Group reported a 6.67% stake in Arcturus Therapeutics Holdings Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 6.67% stake in Arcturus Therapeutics Holdings Inc., 1,810,165 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G/A).
- Stake
- 6.67%
- Shares
- 1,810,165
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 6.67% | 1,810,165 |
Source
Related
- Arcturus Therapeutics Holdings Inc.
- The Vanguard Group
- Arcturus Therapeutics Holdings Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · Federated Hermes, Inc. · Oct 7, 2026
- Schedule 13G/A · ARK Investment Management LLC · May 7, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Feb 17, 2026
- Schedule 13G/A · ARK Investment Management LLC · Feb 3, 2026
- Schedule 13G/A · Federated Hermes, Inc. · Jan 8, 2026